You are viewing the public part of the archive. Login or request access to view more content.
Displaying 1-8 of 8 results
00:14:05
2014_35
Interview with Don Baxter, an HIV activist for more then 30 years, and cutaways in his home.
2014_35
00:11:53
2012_98
XIX International AIDS Conference. Interview with Michel Kazatzhkine who is the United Nations HIV Special Representative for Eastern Europe and Central Asia. Here he talks about harm reduction policies and the situation for people who are using drugs.
2012_98
00:11:23
2012_91
Dr Anthony Fauci from the National Institutes of Health (NIH) gives his thoughts on the future of the AIDS epidemic. He also talks about the targets of the current and future HIV/AIDS research and about international partnerships in the AIDS response.
2012_91
02:49:37
2012_24
Closing session of the XIX International AIDS Conference with speakers such as Bill Clinton, the two co-chairs of the conference Elly Katabira and Diane Havlir, US politician Nancy Pelosi, Françoise Barré-Sinoussi, and many activists and community leaders.
2012_24
00:39:12
2012_17
XIX International AIDS Conference in Washington D.C. Session on drug policy with speakers from the political and scientific community. They talk about harm reduction and political leadership. Chaired by Christopher Beyrer from John Hopkins University.
2012_17
00:17:01
2008_75_01
XVII International AIDS Conference in Mexico City. Interview with Carissa Etienne, Assistant Director-General at WHO and Jim Yong Kim, Professor and since 2012 President of The World Bank. They talk about the leadership of Jonathan Mann and Peter Piot.
2008_75_01
00:16:51
2008_74_06
XVII International AIDS Conference in Mexico City. Interview with Carissa Etienne, Assistant Director-General at WHO and Jim Yong Kim, Professor and since 2012 President of The World Bank. They talk about the leadership of Jonathan Mann and Peter Piot.
2008_74_06
00:44:42
2003_7_02
Sten Vermund from University of Alabama reflects on the history of the global AIDS epidemic and his involvement in the field as a young scientist in the 80's. He discusses the social and economic factors of HIV/AIDS, such as stigma, poverty and the drug industry.
2003_7_02